- Oncology Voice Network
- Joined on Nov 19, 2025
Cel's Feed
67 items published
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
<p>In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how earl...
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
<p>In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., ...
Humans Beyond the Algorithm: Hiring for Oncology’s Future
<p>In episode 4 of Oncology Voice Network Podcast, Host Dr. Kirk Shepard welcomes Stacey Benefiel, PharmD, Head of Global Clinical and Medical Affairs at Canopy, for a candid exploration of what...
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
<p>In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City o...
Navigating the Future of CDXs in Oncology
<p>CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.</p>
How Cross-Functional Teams Reshape Cancer Care
<p>In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-publi...
How Team Science Fuels Cancer Breakthroughs: A Conversation with Dr. Marcel van den Brink
<p>In the season 4 premiere of On the Edge of Breakthrough: Voices of Cancer Research, Monty Pal, M.D., F.A.S.C.O., welcomes Marcel van den Brink, M.D., Ph.D., President of City of Hope Los Ange...
Trust, Transparency & Timelines: Advancing Cancer Care
<p>In episode 2 of the Oncology Voice Network Podcast, Rebecca Goldstein joins Dr. Kirk Shepard to share her vision for the OVN community: a space where real collaboration happens between manufa...
How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD
<p>Join host Michael Pietrack on the PharmaVerse Podcast as he speaks with Dr. Kirk Shepard, Chief Medical Officer of PDS Biotechnology, co-founder of the Medical Affairs Professional Society (M...
FFPE: The Workhorse Behind NGS Testing
<p>Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.</p>
How Mentorship Sparks Innovation: A Conversation with Dr. Wesley Yip
<p>In the season 3 finale episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Wesley Yip, M.D., Assistant Professor, Division of Urology and Urologic Oncolo...
BONUS: The Future of Cancer Surgery: Innovations, AI and Remote Robotics
<p>This is an audience favorite episode. Dr. Yuman Fong shares insights on AI, robotics, the future of surgical oncology, plus his groundbreaking work in oncolytic viruses and the importance of ...
The Quest to Cure: Exploring the Latest Frontiers in Autoimmune Disease Treatment
<p>Dr. Monty Pal welcomes Dr. Enrique Montero, research professor within the Arthur Riggs Diabetes & Metabolism Research Institute, to discuss his global journey in immunology and the pionee...
Translating Discovery: Shaping Tomorrow’s Prostate Cancer Therapies
<p>In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Dr. Tanya Dorff, professor in the Department of Medical Oncology & Therapeutics Research ...
Asking the Impossible: How Bold Questions are Unlocking Diabetes Biggest Breakthroughs
<p>In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal sits down with Dr. Alberto Pugliese, Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of th...
ctDNA Breakthroughs in Mesothelioma Care
<p>Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.</p>
Movement as Medicine: The Science Reshaping Oncology
<p>In this episode of "On the Edge of Breakthrough: Voices of Cancer Research," host Dr. Monty Pal welcomes Dr. Lee Jones, Head of the Exercise Oncology Program in the Department of Me...
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
<p>Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.</p>
Season 2, Episode 20: Exploring The ProFound with John Lepore
<p>Join host Michael Pietrack on The Pharmaverse Podcast as he talks with John Lepore, CEO of ProFound Therapeutics, about leadership, career pivots, and the future of pharmaceutical innovation....
Redefining Ovarian Cancer Care with Biomarkers
<p>Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.</p>
Season 2, Episode 17: Ode To The Oncopig with Jessicca Rege
<p>Welcome to The Pharmaverse Podcast, your go-to destination for insights in the pharmaceutical and biotech industry. In this episode, host Michael Pietrack sits down with Jessicca Rege, PhD, C...
How Team Science is Driving Lung Cancer Breakthroughs
<p>Dr. Loretta Erhunmwunsee explores her latest groundbreaking research investigating the impact of air pollution on lung cancer and shares how team science is critical to advancing cancer care ...
Expanding the Reach of TIL Therapy: What Will it Take?
<p>Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.</p>
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
<p>Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.</p>
Rewriting the Rules of Cellular Therapy
<p>Dr. Stephen Forman shares the past, present, and future of cellular therapy and how City of Hope is building care systems to reach more patients.</p>
Rethinking How We Track and Treat Cancer
<p>HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.</p>
At the Crossroads of Cancer and Metabolism
<p>Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.</p>
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
<p>Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.</p>
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
<p>Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.</p>
How a Bold Yes Became a Scientific Breakthrough
<p>Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.</p>
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
<p>What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.</p>
Why Genetic Testing Should Be Standard in Prostate Cancer
<p>Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.</p>
Building the First AI Agent for Cancer Research
<p>Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.</p>
Humanizing Cancer Treatment Through Whole-Person Care
<p>Dr. Betty Ferrell on her global legacy in palliative care and why whole-person treatment is as crucial as fighting cancer itself.</p>
Pushing the Limits of Cancer Research and Surgery
<p>Dr. Mustafa Raoof on PIPAC, pancreatic cancer research, and how global innovation can shape the next chapter of surgical oncology.</p>
Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine
<p>Dr. Ed Kim shares insights on why redefining the standard of care is critical for improving patient outcomes, the future of clinical trials, and the role of integrative medicine in oncology.&...
The Future of Cancer Surgery: Innovations, AI, and Remote Robotics
<p>Dr. Yuman Fong shares insights on AI, robotics, the future of surgical oncology, plus his groundbreaking work in oncolytic viruses and the importance of mentorship.</p>
Advancing Cancer Survivorship and Cardio-Oncology
<p>Dr. Saro Armenian discusses breakthroughs in cancer survivorship, pediatric oncology and City of Hope’s pioneering work in cardio-oncology.</p>
Driving Therapeutic Impact: A Novel Model for Strategic Medical Affairs Integration
<div class="gt-module gt-module-text gt-module-text-10 large-text"> <p>Integrating Medical Affairs early in drug development transforms the process by enhancing scientific strat...
Season 1, Episode 4: Climbing Your Internal Everest with Samuel Blackman
<p>In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Samuel Blackman, the co-founder and head of R&D at Day One Biopharmaceuticals. Sam shares his experience trekk...